Bindarit, a CCL2, CCL7 and CCL8 inhibitor, is an anti-inflammatory agent.

DAPTA is a potent and selective CCR5 antagonist.

Potent and selective CCR3 antagonist

PF-4136309 is a potent, Selective, and orally bioavailable CCR2 antagonist.

INCB3344 is a potent and selective small molecule antagonist of the mouse CCR2 receptor and inhibits the binding of CCL2 to mouse monocytes with nanomolar potency (IC50 = 10 nM).

PF-4136309 is an orally available CCR2 antagonist with potential immunomodulating and antineoplastic activities.

BMS CCR2 22 is a high affinity CCR2 chemokine receptor antagonist with IC50 of 5.1 nM.

ZK756326 is a full agonist of CCR8（Chemokine receptor 8） with an IC50 of 1.8 μM, dose-responsively eliciting an increase in intracellular calcium and cross-desensitizing the response of the receptor to CCL1.

BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.

K777 is an irreversible inhibitor of cysteine protease inhibitor and a antagonist of CCR4.